Routine blood chemistry offered only faint clues to semen quality in this health-check cohort
Routine biochemical indices and semen parameters moved together only slightly in a cross-sectional study of men attending health examination, and the pattern never sharpened into a robust signal once multiple testing was taken seriously. In 264 men aged 21 to 60 years, investigators examined nine semen outcomes against 42 clinical and biochemical variables, generating 378 correlation tests. The overall message was restrained: the strongest associations were weak, with absolute correlation coefficients no higher than 0.21.
That matters because semen analysis is often treated as a readout of systemic health, yet the body’s laboratory chemistry does not appear to map neatly onto sperm function in a routine screening population. Biological plausibility still exists. Oxidative stress, membrane integrity, acid-base balance, and mineral homeostasis can influence motility, morphology, and chromatin stability. But this dataset suggests those pathways are either subtle, indirect, or obscured by the variability of real-world health-check populations.
Six nominal associations appeared, then faded under broader correction
After Benjamini–Hochberg correction applied within each semen outcome, six associations met the outcome-specific false discovery rate threshold. Magnesium tracked with progressive motility, with ρ = 0.210 and FDR P = 0.025. Normal morphology showed three separate associations: positive correlations with globulin and CO2 combining power, and a negative correlation with albumin-to-globulin ratio. Sodium and calculated serum osmolality were each associated with DNA fragmentation index, with positive correlations of similar size.
Those signals are biologically interpretable, even if they are not definitive. Magnesium influences energy handling, membrane stability, and enzymatic reactions, any of which could affect sperm movement. Serum osmolality and sodium reflect fluid balance and cellular stress states, conditions that may matter for chromatin packaging and sperm DNA integrity. The albumin-to-globulin ratio may serve as a coarse proxy for inflammatory or nutritional status, both of which can affect reproductive physiology. Still, the correlations were weak enough that bedside meaning remains limited without replication.
A single-pass statistical screen can make modest associations look more persuasive than they are.
The picture changed when multiplicity was widened across all 378 tests. None of the six associations survived the global false discovery rate sensitivity analysis, where each had FDR P = 0.123. In practical terms, the study produced suggestive leads, not durable biomarkers.
WHO reference categories did not separate on routine laboratory markers
Investigators also compared men whose semen parameters all fell within WHO 2010 reference limits with men who had at least one parameter below those limits. No clinical or biochemical variable differed significantly between the two groups after false discovery correction. The same absence of separation held in a sensitivity analysis using WHO 2021 criteria, where all q values were at least 0.897.
That null finding is clinically important because it argues against an easy screening shortcut. Routine blood chemistry did not distinguish men with globally “normal” semen from those with at least one abnormal parameter, at least in this cohort. A clinician hoping to infer semen quality from standard laboratory panels would find little support here.
The post hoc supportive model for osmolality and normal morphology was reported separately in the supplementary material, but it did not alter the central message. The most generous interpretation is that routine systemic markers may capture fragments of the biology, not the whole story.
Cross-sectional design limits causal claims and timing questions
Because the analysis was retrospective and cross-sectional, every association is a snapshot rather than a trajectory. There is no way to determine whether biochemical variation preceded semen changes, followed them, or arose from an unrelated process. That limitation is especially relevant in male reproductive research, where sperm production reflects a long biological timeline and is vulnerable to fever, medications, lifestyle exposures, metabolic health, and transient environmental stressors.
The study also depended on routinely collected health-check data, which increases real-world relevance but reduces experimental control. Men in a screening setting are rarely homogeneous. Hidden differences in diet, recent illness, abstinence interval, exercise, smoking, alcohol use, or unmeasured endocrine status could all blur associations. Even with 264 participants, the analysis may have been underpowered to detect very small effects once 378 tests and multiplicity correction were applied.
What this adds to male fertility workups
For clinicians, the value of the study lies less in a new biomarker than in its restraint. It shows that common chemistry panels and semen measures are not tightly coupled in an unselected health-examination cohort. If a relationship exists, it is likely modest and context-dependent rather than a simple one-marker explanation for impaired semen quality.
For researchers, the signal is still useful. Sodium, osmolality, magnesium, and proteins tied to the albumin-globulin balance deserve confirmation in longitudinal datasets that can track repeated semen testing, hormonal profiling, and metabolic status over time. If future work can align these measures with oxidative stress markers, inflammatory indices, and lifestyle exposures, the biological pathway may become clearer. For now, the evidence supports caution: routine systemic biochemical indices may offer hints about semen physiology, but they do not yet provide a dependable clinical window into sperm quality.